机译:选择的基因预后分析辅助化疗患者的T3、舞台二世结肠癌:对质量调整生命的影响预期寿命和成本
Stanford University, School of Medicine, Stanford, CA, United States, Cedar Associates LLC, Menlo;
Duke University, Duke Cancer Institute, Durham, NC, United States;
Cedar Associates LLC, Menlo Park, CA, United States, Mailman School of Public Health, ColumbiaUniversity Hospitals Case Medical Center, Seidman Cancer Center, Case Western Reserve University;
Adjuvant Chemotherapy; life expectancy; health economicstechnological changestage II colon cancerDNA Mismatch RepairCost EffectivenessT3 Stage Finding;
机译:Suboptimal Completion Rates, Adverse Events, Costs, Resource Utilization, and Cost Impact of Noncompletion in Oral Adjuvant Capecitabine-Based Chemotherapy in Patients With Early-Stage Colon Cancer
机译:Cost-utility analysis of adjuvant chemotherapy in patients with stage III colon cancer in Thailand
机译:Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials